Concert Wealth Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Concert Wealth Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,961	Closed	-$5K	–	1005
2016 Q3	$5K	Buy	+14,961	New	+$5K	﹤0.01%	972

Concert Wealth Management's RXII Position: Q4 2016 in Review

Concert Wealth Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 14,961 shares — an estimated $5K sold.

Concert Wealth Management first reported a position in RXII in Q3 2016 and held it in 1 quarter. The position peaked at $5K in Q3 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Concert Wealth Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Concert Wealth Management sold 14,961 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $5K.
Concert Wealth Management first reported a position in GALENA BIOPHARMA INC COM in Q3 2016 and held it in 1 quarter.
Concert Wealth Management's GALENA BIOPHARMA INC COM position peaked at $5K in Q3 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Concert Wealth Management's 13F filing for Q4 2016, filed 10 Feb 2017.